Extractas Bioscience Overview

  • Year Founded
  • 1975

Year Founded

  • Status
  • Private

  • Employees
  • 85

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

Extractas Bioscience General Information

Description

Manufacturer of botanical extracts and purified products intended to support the production of active pharmaceutical ingredients. The company specializes in the research, manufacturing and export of alkaloid raw materials, cannabis full plant extracts and cannabis isolates, enabling its clients to get medicinal opiates from patented poppy varieties grown on the farms of Tasmania conveniently.

Contact Information

Formerly Known As
Tasmanian Alkaloids
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • P.O. Box 130
  • 160 Birralee Road
  • Westbury, Tasmania 7303
  • Australia
+61 (03)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • P.O. Box 130
  • 160 Birralee Road
  • Westbury, Tasmania 7303
  • Australia
+61 (03)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Extractas Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Extractas Bioscience‘s full profile, request access.

Request a free trial

Extractas Bioscience Patents

Extractas Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018900692-A0 A plant of papaver somniferum with an altered alkaloid profile Inactive 02-Mar-2018
US-20210000061-A1 A plant of papaver somniferum with an altered alkaloid profile Inactive 02-Mar-2018
EP-3758728-A1 A plant of papaver somniferum with an altered alkaloid profile Inactive 02-Mar-2018
EP-3758728-A4 A plant of papaver somniferum with an altered alkaloid profile Inactive 02-Mar-2018
AU-2019226633-A1 A plant of papaver somniferum with an altered alkaloid profile Inactive 02-Mar-2018 A01H6/64
To view Extractas Bioscience’s complete patent history, request access »

Extractas Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Extractas Bioscience Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Extractas Bioscience‘s full profile, request access.

Request a free trial

Extractas Bioscience FAQs

  • When was Extractas Bioscience founded?

    Extractas Bioscience was founded in 1975.

  • Where is Extractas Bioscience headquartered?

    Extractas Bioscience is headquartered in Westbury, Australia.

  • What is the size of Extractas Bioscience?

    Extractas Bioscience has 85 total employees.

  • What industry is Extractas Bioscience in?

    Extractas Bioscience’s primary industry is Pharmaceuticals.

  • Is Extractas Bioscience a private or public company?

    Extractas Bioscience is a Private company.

  • What is Extractas Bioscience’s current revenue?

    The current revenue for Extractas Bioscience is .

  • Who are Extractas Bioscience’s investors?

    SK Capital Partners has invested in Extractas Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »